Professional Advisory Services’s Oncolytics Biotech ONCY Stock Holding History

Professional Advisory Services’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19K	Hold	20,000	–	–	﹤0.01%	92
2026 Q1	$17K	Hold	20,000	–	–	﹤0.01%	80
2025 Q4	$17K	Hold	20,000	–	–	﹤0.01%	80
2025 Q3	$28K	Hold	20,000	–	–	﹤0.01%	81
2025 Q2	$15K	Buy	20,000 +5,000	+33%	+$2.65K	﹤0.01%	81
2025 Q1	$8K	Buy	15,000 +5,000	+50%	+$3.66K	﹤0.01%	80
2024 Q4	$9K	Hold	10,000	–	–	﹤0.01%	76
2024 Q3	$9K	Hold	10,000	–	–	﹤0.01%	79
2024 Q2	$10K	Hold	10,000	–	–	﹤0.01%	76
2024 Q1	$11K	Buy	+10,000	New	+$11.2K	﹤0.01%	75

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

BPWM

Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Professional Advisory Services's ONCY Position: Q2 2026 in Review

Professional Advisory Services held its Oncolytics Biotech (ONCY) position steady in Q2 2026 at 20,000 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #92.

Professional Advisory Services first reported a position in ONCY in Q1 2024 and has held it in 10 quarters since. The position peaked at $28K in Q3 2025. 24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

Professional Advisory Services held 20,000 shares of Oncolytics Biotech worth $19K as of Q2 2026.
Professional Advisory Services left its Oncolytics Biotech share count unchanged in Q2 2026.
Oncolytics Biotech made up ﹤0.01% of Professional Advisory Services's portfolio in Q2 2026, its #92 holding.
Professional Advisory Services first reported a position in Oncolytics Biotech in Q1 2024 and has held it in 10 quarters since.
Professional Advisory Services's Oncolytics Biotech position peaked at $28K in Q3 2025.
24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Professional Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.